Previous close | 2.0900 |
Open | 2.1400 |
Bid | 2.0300 x 100 |
Ask | 2.2400 x 100 |
Day's range | 2.1001 - 2.2200 |
52-week range | 0.3300 - 3.4720 |
Volume | |
Avg. volume | 444,762 |
Market cap | 21.632M |
Beta (5Y monthly) | 5.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.1400 |
Earnings date | 10 May 2024 - 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.00 |
Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced the sale of new three-year, $11.83 million convertible notes to funds managed by JGB Management Inc.
Marpai, Inc. (NASDAQ:MRAI) Q4 2023 Earnings Call Transcript March 27, 2024 Marpai, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the Marpai Fourth Quarter and Fiscal Year 2023 Earnings Conference Call. All participants will […]